Banner

Influenza Diagnostic Global Market Report 2023 – By Traditional diagnostic tests (Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests), By Molecular diagnostic tests (Reverse Transcription Polymerase Chain Reaction (RTPCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By EndUsers (Hospitals & Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : January 2023 | SKU CODE : r543 | Delivery Time: 2-3 business days | Format :


Influenza diagnostic is the test used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting diagnostics tests for influenza virus detection.

The main traditional diagnostic test types of influenza diagnostics are rapid influenza diagnostic tests (RIDT), viral culture, DFA, serological assays and others. Rapid influenza diagnostic tests (RIDTs) are immunoassays that can detect the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and provide a qualitative result (positive vs. negative). The various molecular diagnostic tests include Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), loop mediated isothermal based amplification assays, transcription mediated isothermal based amplification assays, transcription mediated isothermal based amplification assays, other isothermal nucleic acid amplification tests and are used by hospitals and clinical laboratories, diagnostic reference laboratories, academic/research institutes, other end users.

The influenza diagnostic market research report is one of a series of new reports from The Business Research Company that provides influenza diagnostic market statistics, including influenza diagnostic industry global market size, regional shares, competitors with a influenza diagnostic market share, detailed influenza diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the influenza diagnostic industry. This influenza diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global influenza diagnostic market size will grow from $2.42 billion in 2022 to $2.59 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global influenza diagnostic market size is expected to grow to $3.37 billion in 2027 at a CAGR of 6.8%.

The major factor driving the market is increasing funding for research on influenza diagnostics. Addressing the public health impact of influenza disease requires a proper understanding of the virus and its effect on individuals and populations. Therefore, it is important to accelerate the pace of scientific research progress that can have the greatest public health impact. Many public and private health organizations, researchers, health professionals, biopharmaceutical companies have maximized the spending for research funds or grants to reduce the risk of the emergence of pandemic influenza. For instance,in April 2021, the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health, funded $24 million to help five Centres of Excellence for Influenza Research and Response (CEIRR), including the one at St. Jude Children's Research Hospital. More than $8.9 million of the first year's funding for St. Jude's research provided by the federal contract was to understand better, forecast, track, and treat developing influenza and other viruses.

The variability in sensitivity and specificity among the influenza diagnostic tests is restraining the growth of the market. In most rapid flu tests, there are difficulties in identifying patients with influenza. The sensitivity of rapid flu tests ranges from 10-80% across various patient populations. Most diagnostic tests show an increase in the rate of false-negative results during low influenza virus activity, which often leads to an incorrect diagnosis. Thus, the variability in sensitivity and specificity is restraining the growth of the influenza diagnostic market.

Rapid influenza diagnostic tests (RIDTs) are increasingly being implemented in influenza diagnostics. RIDTs are immunoassays which can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and display the result in a qualitative way (positive vs. negative). It can yield results in a clinically relevant time frame of less than approximately 15 minutes and diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms. The rising popularity of RIDT is due to the benefits such as simple to use and rapid diagnosis.

In February 2021, Thermo Fisher Scientific Inc., a US-based company specialising in clinical development, acquired Mesa Biotech, Inc. for an undisclosed amount. Through this acquisition, Thermo Fisher will increase manufacturing volume, achieve cost efficiencies, and deliver much-needed diagnostics to market faster and at a larger scale. Mesa Biotech, Inc. is a US-based infectious disease diagnostic company.

Major players in the influenza diagnostics market are F. Hoffmann-La Roche Ltd., Quidel Corporation, ?h?rm? F??h?r, Abbott Laboratories, Hologic, Becton Dickinson and Company, DiaSorin S.p.A., Luminex Corporation, Meridian Bioscience Inc. and GenMark Diagnostics.

North America was the largest region in the influenza diagnostics market in 2022. Western Europe was the second largest region in the global influenza diagnostics market. The regions covered in the global influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the influenza diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The influenza diagnostic market includes revenue earned by test kit and reagents, and other products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global influenza diagnostic market is segmented -

1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests

2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

3) By End User: Hospitals & Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Table Of Contents

    1. Executive Summary

    2. Influenza Diagnostics Market Characteristics

    3. Influenza Diagnostics Market Trends And Strategies

    4. Influenza Diagnostics Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Influenza Diagnostics Market

    4.2 Ukraine-Russia War Impact On Influenza Diagnostics Market

    4.3 Impact Of High Inflation On Influenza Diagnostics Market

    5. Influenza Diagnostics Market Size And Growth

    5.1. Global Influenza Diagnostics Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Influenza Diagnostics Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Influenza Diagnostics Market Segmentation

    6.1. Global Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Rapid influenza diagnostic tests (RIDT)

    Viral Culture

    DFA

    Serological assays

    Other Traditional diagnostic tests

    6.2. Global Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    Isothermal Nucleic Acid Amplification Tests (INAAT)

    Loop Mediated Isothermal Based Amplification Assays

    Transcription Mediated Isothermal Based Amplification Assays

    Transcription Mediated Isothermal Based Amplification Assays

    Other Isothermal Nucleic Acid Amplification Tests

    Other Molecular Diagnostic Tests

    6.3. Global Influenza Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals & Clinical Laboratories

    Diagnostic Reference Laboratories

    Academic/Research Institutes

    Other End Users

    7. Influenza Diagnostics Market Regional And Country Analysis

    7.1. Global Influenza Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Influenza Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Influenza Diagnostics Market

    8.1. Asia-Pacific Influenza Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Influenza Diagnostics Market

    9.1. China Influenza Diagnostics Market Overview

    9.2. China Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Influenza Diagnostics Market

    10.1. India Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Influenza Diagnostics Market

    11.1. Japan Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Influenza Diagnostics Market

    12.1. Australia Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Influenza Diagnostics Market

    13.1. Indonesia Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Influenza Diagnostics Market

    14.1. South Korea Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Influenza Diagnostics Market

    15.1. Western Europe Influenza Diagnostics Market Overview

    15.2. Western Europe Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Influenza Diagnostics Market

    16.1. UK Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Influenza Diagnostics Market

    17.1. Germany Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Influenza Diagnostics Market

    18.4. France Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Influenza Diagnostics Market

    19.1. Eastern Europe Influenza Diagnostics Market Overview

    19.2. Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Influenza Diagnostics Market

    20.1. Russia Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Influenza Diagnostics Market

    21.1. North America Influenza Diagnostics Market Overview

    21.2. North America Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Influenza Diagnostics Market

    22.1. USA Influenza Diagnostics Market Overview

    22.2. USA Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Influenza Diagnostics Market

    23.1. South America Influenza Diagnostics Market Overview

    23.2. South America Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Influenza Diagnostics Market

    24.1. Brazil Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Influenza Diagnostics Market

    25.1. Middle East Influenza Diagnostics Market Overview

    25.2. Middle East Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Influenza Diagnostics Market

    26.1. Africa Influenza Diagnostics Market Overview

    26.2. Africa Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Influenza Diagnostics Market Competitive Landscape And Company Profiles

    27.1. Influenza Diagnostics Market Competitive Landscape

    27.2. Influenza Diagnostics Market Company Profiles

    27.2.1. F. Hoffmann-La Roche Ltd

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Quidel Corporation

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. ?h?rm? F??h?r

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Abbott Laboratories

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Hologic

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Influenza Diagnostics Market

    29. Influenza Diagnostics Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Influenza Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Influenza Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Influenza Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 47: Quidel Corporation Financial Performance
  • Table 48: ?h?rm? F??h?r Financial Performance
  • Table 49: Abbott Laboratories Financial Performance
  • Table 50: Hologic Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Influenza Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Influenza Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Influenza Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 47: Quidel Corporation Financial Performance
  • Figure 48: ?h?rm? F??h?r Financial Performance
  • Figure 49: Abbott Laboratories Financial Performance
  • Figure 50: Hologic Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report